日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Brentuximab vedotin and nivolumab in combination with chemotherapy for nonbulky, early-stage classical Hodgkin lymphoma

Brentuximab vedotin 和 nivolumab 联合化疗治疗非肿块型早期经典霍奇金淋巴瘤

Abramson, Jeremy S; Straus, David J; Bartlett, Nancy L; Burke, John M; Lynch, Ryan C; Domingo Domenech, Eva; Hess, Brian; Schuster, Steven R; Linhares, Yuliya; Gandhi, Mitul; Shah, Harsh R; Jurczak, Wojciech; Re, Alessandro; Hahn, Uwe; Prince, H Miles; Guo, Wenchuan; Davis, Griffith; Ho, Linda; Fanale, Michelle; Yasenchak, Christopher A; Lee, Hun Ju

Correction: Brentuximab vedotin plus chemotherapy for the treatment of front-line systemic anaplastic large cell lymphoma: subgroup analysis of the ECHELON-2 study at 5 years' follow-up

更正:Brentuximab vedotin联合化疗一线治疗系统性间变性大细胞淋巴瘤:ECHELON-2研究5年随访亚组分析

Domingo-Domènech, Eva; Pro, Barbara; Illidge, Tim; Horwitz, Steven; Trumper, Lorenz; Iyer, Swami; Advani, Ranjana; Bartlett, Nancy L; Christensen, Jacob Haaber; Kim, Won-Seog; Feldman, Tatyana; Choi, Ilseung; Gritti, Giuseppe; Belada, David; Shustov, Andrei; Illes, Arpad; Zinzani, Pier Luigi; Hüttmann, Andreas; Trneny, Marek; Le Gouill, Steven; Jagadeesh, Deepa; Friedberg, Jonathan W; Little, Meredith; Dong, Cassie; Fanale, Michelle; Fenton, Keenan; Savage, Kerry J

An intriguing journey into the hereditary syndromes predisposing to endometrial cancer: more than believed

一段引人入胜的探索之旅,揭示了导致子宫内膜癌的遗传综合征:远超人们的想象。

Fanale, Daniele; Magrin, Luigi; Corsini, Lidia Rita; Pedone, Erika; Brando, Chiara; Bazan Russo, Tancredi Didier; Ferraro, Pietro; Carobene, Karen; Cipolla, Elga Adriana; Colletta, Giovanni; Puglisi, Mattia; Galvano, Antonio; Vieni, Salvatore; Pantuso, Gianni; Giannone, Antonino Giulio; Badalamenti, Giuseppe; Incorvaia, Lorena; Russo, Antonio; Bazan, Viviana

Nivolumab plus brentuximab vedotin for relapsed/refractory diffuse large B-cell lymphoma

纳武利尤单抗联合维布妥昔单抗治疗复发/难治性弥漫性大B细胞淋巴瘤

Johnson, Nathalie A; Zinzani, Pier Luigi; Domingo-Domenech, Eva; Brody, Joshua; Kline, Justin; Shah, Bijal Dinesh; Mehta, Amitkumar Nitinkumar; Ghesquieres, Herve; Savage, Kerry J; Barr, Paul M; Santoro, Armando; Ferrari, Silvia; Cunningham, David; Collins, Graham P; Fanale, Michelle; Krajewski, Jennifer; Akyol, Alev; Crowe, Russell; Wen, Rachael; Kuruvilla, John

Brentuximab Vedotin Combination for Relapsed Diffuse Large B-Cell Lymphoma

布伦妥昔单抗联合维多汀治疗复发性弥漫性大B细胞淋巴瘤

Bartlett, Nancy L; Hahn, Uwe; Kim, Won-Seog; Fleury, Isabelle; Laribi, Kamel; Bergua, Juan-Miguel; Bouabdallah, Krimo; Forward, Nicholas; Bijou, Fontanet; MacDonald, David; Portell, Craig A; Ghesquieres, Herve; Nowakowski, Grzegorz; Yasenchak, Christopher A; Patterson, Monica; Ho, Linda; Rustia, Evelyn; Fanale, Michelle; Jie, Fei; Kim, Jeong-A

Brentuximab vedotin plus chemotherapy for the treatment of front-line systemic anaplastic large cell lymphoma: subgroup analysis of the ECHELON-2 study at 5 years' follow-up

Brentuximab vedotin联合化疗一线治疗系统性间变性大细胞淋巴瘤:ECHELON-2研究5年随访亚组分析

Domingo-Domènech, Eva; Pro, Barbara; Illidge, Tim; Horwitz, Steven; Trumper, Lorenz; Iyer, Swami; Advani, Ranjana; Bartlett, Nancy L; Christensen, Jacob Haaber; Kim, Won-Seog; Feldman, Tatyana; Choi, Ilseung; Gritti, Giuseppe; Belada, David; Shustov, Andrei; Illes, Arpad; Zinzani, Pier Luigi; Hüttmann, Andreas; Trneny, Marek; Le Gouill, Steven; Jagadeesh, Deepa; Friedberg, Jonathan W; Little, Meredith; Dong, Cassie; Fanale, Michelle; Fenton, Keenan; Savage, Kerry J

BRCA functional domains associated with high risk of multiple primary tumors and domain-related sensitivity to olaparib: the Prometheus Study

BRCA功能域与多原发肿瘤高风险相关,且对奥拉帕尼具有结构域相关性敏感性:普罗米修斯研究

Incorvaia, L; Marchetti, C; Brando, C; Bazan Russo, T D; Bono, M; Perez, A; Congedo, L; Ergasti, R; Castellana, L; Insalaco, L; Contino, S; Gristina, V; Galvano, A; Fanale, D; Badalamenti, G; Russo, A; Scambia, G; Bazan, V

Association of PET4 response with outcomes of BV-CHP vs CHOP in the ECHELON-2 trial in CD30+ peripheral T-cell lymphoma

ECHELON-2试验中,PET4反应与CD30+外周T细胞淋巴瘤患者BV-CHP方案与CHOP方案疗效的相关性

Iyer, Swaminathan; Mehta-Shah, Neha; Advani, Ranjana; Bartlett, Nancy L; Christensen, Jacob H; Morschhauser, Franck; Domingo-Domenech, Eva; Rossi, Giuseppe; Kim, Won Seog; Alpdogan, Onder; Feldman, Tatyana A; Camus, Vincent; Gritti, Giuseppe; Zinzani, Pier Luigi; Belada, David; Mayer, Jiri; Choi, Ilseung; Cheong, June-Won; Rustia, Evelyn; Fenton, Keenan; Fanale, Michelle; Savage, Kerry J; Horwitz, Steven M

POLE-mutated endometrial cancer: new perspectives on the horizon?

POLE基因突变的子宫内膜癌:新的研究方向即将到来?

Fanale, Daniele; Corsini, Lidia Rita; Piraino, Paola; Pedone, Erika; Brando, Chiara; Bazan Russo, Tancredi Didier; Ferraro, Pietro; Simone, Alisia; Contino, Silvia; Prestifilippo, Ornella; Randazzo, Ugo; Giurintano, Ambra; Ferrante Bannera, Carla; Galvano, Antonio; Incorvaia, Lorena; Pernice, Gianfranco; Vieni, Salvatore; Pantuso, Gianni; Cipolla, Calogero; Giannone, Antonino Giulio; Badalamenti, Giuseppe; Russo, Antonio; Bazan, Viviana

Plain language summary of the ECHELON-3 study: brentuximab vedotin combination treatment in people with diffuse large B-cell lymphoma

ECHELON-3 研究的简明语言摘要:brentuximab vedotin 联合治疗弥漫性大 B 细胞淋巴瘤患者

Bartlett, Nancy L; Hahn, Uwe; Kim, Won-Seog; Fleury, Isabelle; Laribi, Kamel; Bergua, Juan-Miguel; Bouabdallah, Krimo; Forward, Nicholas; Bijou, Fontanet; MacDonald, David; Portell, Craig A; Ghesquieres, Herve; Nowakowski, Grzegorz; Yasenchak, Christopher A; Patterson, Monica; Ho, Linda; Rustia, Evelyn; Fanale, Michelle; Jie, Fei; Kim, Jeong-A